Management of idiopathic ventricular fibrillation: Implantable defibrillators? Antiarrhythmic drugs?

Annals of Noninvasive Electrocardiology

Volumn 3, Issue 2, 1998, Pages 125-128

  Belhassen, Bernard ^a,b   Viskin, Sami ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Antiarrhythmic therapy; Automatic defibrillators; Idiopathic ventricular fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; LAXATIVE; PROCAINAMIDE; QUINIDINE; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEFIBRILLATION; DRUG INDUCED DISEASE; FEMALE; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOKALEMIA; IDIOPATHIC DISEASE; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031947332     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474x.1998.tb00409.x     Document Type: Article

References (20)

1. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 1990;120:661-671.
2. Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol 1993;4:356-368.
3. Wichter T, Breithardt G, Borggrefe M. Ventricular tachycardia in the normal heart. Chapter in PJ Podrid, PR Kowey. Cardiac Arrhythmia - Mechanisms, Diagnosis and Management. William and Wilkens, Baltimore, 1995:1219-1238.
4. Dock W. Transitory ventricular fibrillation as a cause of syncope and its prevention by quinidine sulfate. Am Heart J 1929;4:709-714.
5. Belhassen B, Shapira I, Shoshani D, et al. Idiopathic ventricular fibrillation: Inducibility and beneficial effects of class I antiarrhythmic agents. Circulation 1987;75:809-816.
6. Priori SG, Borggrefe M, Camm AJ, et al. Unexplained cardiac arrest. The need for a prospective registry. Eur Heart J 1992;13:1445-1446.
7. Priori SG, Borggrefe M, Camm AJ, et al. Role of the implantable defibrillator in patients with idiopathic ventricular fibrillation. Data from the UCARE International Registry, (abstract) PACE 1995;18:799.
8. Nunain SO, Roelke M, Trouton T, et al. Limitations and late complications of third-generation automatic cardioverterdefibrillators. Circulation 1995;91:2204-2213.
9. Schwartzman D, Nallamothu N, Callans DJ, et al. Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. J Am Coll Cardiol 1995; 26:776-786.
10. Mason JW, for the Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic efficacy for ventricular tachyarrhythmias. N Engl J Med 1993;329:445-451.
11. Mason JW, for the Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-458.
12. Belhassen B, Shapira I, Sheps D, et al. Programmed ventricular stimulation using up to two extrastimuli and repetition of double extrastimulation for induction of ventricular tachycardia: A new highly sensitive and specific protocol. Am J Cardiol 1990;65:615-622.
13. Mewis C, Bosch RF, Tropitzsch A, et al. Favorable prognosis in untreated patients with idiopathic ventricular fibrillation, (abstract) PACE 1995;18:940.
14. Aizawa Y, Naitoh N, Washizuka T, et al. Electrophysiological findings in idiopathic ventricular fibrillation: Special reference to mode of induction, drug testing and long-term outcomes. PACE 1996;19:929-939.
15. Moe T. Morgagni-Adams-Stokes attacks caused by transient recurrent ventricular fibrillation in a patient without apparent organic heart disease. Am Heart J 1949;37:811-818.
16. Kontny F, Dale J. Self-terminating idiopathic ventricular fibrillation presenting as syncope: A 40-year follow-up report. J Intern Med 1990;227:211-213.
17. Guidelines for the Use of Implantable Cardioverter Defibrillators. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Eur Heart J 1992;13:1304-1310.
18. Josephson ME. ICD implantation: Cost conscious or patient conscious. J Cardiovasc Electrophysiol 1996;7:202-205.
19. Dolack GL, Poole JE, Kudenchuk P, et al. Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugs. J Cardiovasc Electrophysiol 1996;7:197-202.
20. Belhassen B. Transvenous defibrillators without EP testing. (letter) J Cardiovasc Electrophysiol 1996;7:790-791.